Concarlo Therapeutics at TPD Summit 2026

Oct 26–29, 2026 Boston, MA ~300 attendees Website

Concarlo Therapeutics takes part in 3 sessions at TPD Summit 2026 in Boston. Its sessions focus on ligases beyond cereblon, rational and structural design, and Locktacs, molecular glue stabilizers for p27 and other intrinsically disordered proteins.

OrganizationTPD Summit 2026 Attendance
concarlo.com
Biotech
Develops cancer therapeutics built on p27 biology, including molecular glue stabilizers, for drug-resistant cancers.
Chair
Panel
Tue Oct 27
3:10pm
Harnessing Rational Design and Structural Insights to Develop Induced Proximity Molecules with Enhanced Translational Potential
Track B: Pre-Clinical Development · with Protai, Biogen, Lyterian Therapeutics +1 more
Degrader discovery & design
Talk
Thu Oct 29
12:15pm
Locktacs for Intrinsically Disordered Proteins: First-in-Class p27 Molecular Glue Stabilizers
Future of Induced Proximity Track
Induced proximity beyond degradation

Explore the full TPD Summit 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full TPD Summit 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Concarlo Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the TPD & Induced Proximity Summit or its organizers. Submit a correction